Oral Cancer Screenings

Introducing the VELscope® Vx Enhanced Oral Assessment System, which centers on a wireless, handheld scope that uses natural tissue fluorescence to enhance the way clinicians visualize oral mucosal abnormalities that might not be apparent or even visible to the naked eye.

Recognized by the World Health Organization in 2009 as a commercialized medical device that addresses global health concerns and is accessible to low and middle-income countries, the award-winning VELscope® Vx is among the world’s most widely used adjunctive devices for the enhanced visualization of oral mucosal abnormalities, such as oral cancer or pre-malignant dysplasia.

Supported by clinical studies illustrating the efficacy of the VELscope’s tissue fluorescence visualization, more than 25 million VELscope® Vx examinations have been performed by over 15,000 dental practitioners in 23 countries worldwide.